We are live on ! Find out more
ALDR

Alder Biopharmaceuticals
ALDR

Delisted

ALDR was delisted on the 21st of October, 2019.

Back to rankings

123 hedge funds and large institutions have $1.21B invested in Alder Biopharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 52 increasing their positions, 27 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more call options, than puts

Call options by funds: $750K | Put options by funds: $373K

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

93% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 27

64% more capital invested

Capital invested by funds: $733M → $1.21B (+$473M)

1% less funds holding

Funds holding: 124 → 123 (-1)

5% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 21

Holders
123
Holders Change
-1
Holders Change %
-0.81%
% of All Funds
2.66%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
20
Increased
52
Reduced
27
Closed
21
Calls
$750K
Puts
$373K
Net Calls
+$377K
Net Calls Change
+$797K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$69.9M
2
PHS
PFM Health Sciences
California
+$29.9M
3
RG
Redmile Group
California
+$22.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$18.1M
5
Norges Bank
Norges Bank
Norway
+$17.5M

Top Sellers

Rank Fund Capital Flow
1
TCIM
TIAA CREF Investment Management
New York
-$8.35M
2
Brown Advisory
Brown Advisory
Maryland
-$7.71M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.62M
4
Citigroup
Citigroup
New York
-$4.07M
5
Deutsche Bank
Deutsche Bank
Germany
-$3.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$11.4M -$1.62M -125,334 -13%
TCIM
27
TIAA CREF Investment Management
New York
$10.2M -$8.35M -644,837 -46%
Northern Trust
28
Northern Trust
Illinois
$10.2M +$629K +48,559 +7%
UBS AM
29
UBS AM
Illinois
$10.1M -$46.1K -3,562 -0.5%
Franklin Resources
30
Franklin Resources
California
$9.9M +$9.39M +725,000 New
DCM
31
DAFNA Capital Management
California
$7.79M +$2.27M +175,000 +44%
AG
32
Artal Group
Luxembourg
$6.83M +$3.89M +300,000 +150%
Charles Schwab
33
Charles Schwab
California
$5.21M +$728K +56,183 +17%
Millennium Management
34
Millennium Management
New York
$4.84M -$1.59M -122,841 -26%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$3.62M -$829 -64 -0%
Bank of America
36
Bank of America
North Carolina
$3.53M +$3.1M +239,005 +1,216%
SSA
37
Schonfeld Strategic Advisors
New York
$3.46M -$1.54M -118,500 -32%
JP Morgan Chase
38
JP Morgan Chase
New York
$3.28M -$202K -15,573 -6%
USAA
39
United Services Automobile Association
Texas
$3.22M +$2.01M +155,200 +192%
FI
40
Fosun International
China
$3.11M +$635K +49,045 +27%
CS
41
Candriam SCA
Luxembourg
$3.11M – – –
TD Asset Management
42
TD Asset Management
Ontario, Canada
$3M +$115K +8,881 +4%
Rafferty Asset Management
43
Rafferty Asset Management
New York
$2.02M +$1.92M +148,134 New
American Century Companies
44
American Century Companies
Missouri
$2M -$92.8K -7,166 -5%
Wells Fargo
45
Wells Fargo
California
$1.84M +$269K +20,758 +18%
Neuberger Berman Group
46
Neuberger Berman Group
New York
$1.83M +$1.6M +123,750 +1,179%
TA
47
Teachers Advisors
New York
$1.77M +$16.2K +1,248 +1%
UBS Group
48
UBS Group
Switzerland
$1.66M +$259K +20,005 +20%
Swiss National Bank
49
Swiss National Bank
Switzerland
$1.54M +$45.3K +3,500 +3%
MOACM
50
Mutual of America Capital Management
New York
$1.51M +$26K +2,004 +2%
1
2
3 4 5

ALDR Hedge Fund Activity: Q1 2019 in Review

123 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Alder Biopharmaceuticals (ALDR) for Q1 2019, worth a combined $1.21B — up 64% from $733M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ALDR and 20 opened new positions — a net loss of 1 holder — while 27 trimmed existing stakes and 52 added.

The largest buyer was Wellington Management Group, adding an estimated $69.9M. The largest seller was TIAA CREF Investment Management, cutting an estimated $8.35M.

  • 123 institutional investors held Alder Biopharmaceuticals (ALDR) as of Q1 2019, down from 124 in Q4 2018.
  • Funds reported $1.21B of Alder Biopharmaceuticals stock for Q1 2019, up 64% quarter-over-quarter.
  • 20 funds opened new Alder Biopharmaceuticals positions in Q1 2019 and 21 closed out, a net change of -1 holder.
  • The largest Alder Biopharmaceuticals buyer in Q1 2019 was Wellington Management Group, an estimated $69.9M added.
  • The largest Alder Biopharmaceuticals seller in Q1 2019 was TIAA CREF Investment Management, an estimated $8.35M sold.

Based on aggregated 13F filings for Q1 2019.